PubMed Central (PMC) Search Page
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1994 | 2 |
| 1999 | 1 |
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 3 |
| 2006 | 4 |
| 2007 | 14 |
| 2008 | 12 |
| 2009 | 8 |
| 2010 | 20 |
| 2011 | 15 |
| 2012 | 20 |
| 2013 | 5 |
| 2014 | 12 |
| 2015 | 21 |
| 2016 | 17 |
| 2017 | 20 |
| 2018 | 25 |
| 2019 | 46 |
| 2020 | 88 |
| 2021 | 103 |
| 2022 | 77 |
| 2023 | 104 |
| 2024 | 124 |
| 2025 | 143 |
| 2026 | 47 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Virchows Arch"[Journal]
933
results
Embargoed Articles:
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Emerging concepts and recent advances in renal cell neoplasia.
- Trpkov K, Agaimy A.
- Virchows Arch. 2026 Sep;489(3):543-545. doi: 10.1007/s00428-026-04695-9.
- PMCID: PMC13582224
Trpkov K, et al.Virchows Arch. 2026.PMCID: PMC13582224 -
GPR143, a novel immunohistochemical marker for renal tumors with FLCN/TSC/MTOR-TFE alterations.
- Li Q, Singh A, Hu R, Huang W, Shapiro DD, Abel EJ, Zong Y.
- Virchows Arch. 2026 Jul 17;489(3):619-630. doi: 10.1007/s00428-026-04646-4.
- PMCID: PMC13582269
Li Q, et al.Virchows Arch. 2026.PMCID: PMC13582269 -
Comprehensive analysis of six MED15::TFE3 renal cell carcinomas including two novel solid MED15::TFE3 renal cell carcinomas, highlighting their morphologic, immunohistochemical and molecular differences from their cystic counterparts.
- Kwon JW, Lammert SM, Zullow H, Wang P, Tjota MY, Antic T.
- Virchows Arch. 2026 May 11;489(3):669-680. doi: 10.1007/s00428-026-04576-1.
- PMCID: PMC13582055
Kwon JW, et al.Virchows Arch. 2026.PMCID: PMC13582055 -
Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma.
- Marletta S, Fiorini D, Caliò A, Marcolini L, Stefanizzi L, Giacometti C, Pedron S, Vicentini C, Martignoni G.
- Virchows Arch. 2026 Apr 29;489(3):631-651. doi: 10.1007/s00428-026-04536-9.
- PMCID: PMC13582226
Marletta S, et al.Virchows Arch. 2026.PMCID: PMC13582226 -
Immunohistochemical expression of GPNMB in TFEB-rearranged and TFEB-amplified renal cell carcinomas.
- Pivovarcikova K, Grossmann P, Steiner P, Kuthi L, Rogala J, Trpkov K, Lopez JI, Rychly B, Sarvaicova L, Spurkova Z, Nikolov O, Mlynek A, Soukup J, Sehnalkova E, Baumbruk L, Skopal J, Stransky P Jr, Bartos-Vesela A, Pitra T, Hora M, Michal M, Ondic O, Alaghehbandan R.
- Virchows Arch. 2026 Mar 4;489(3):695-705. doi: 10.1007/s00428-026-04466-6.
- PMCID: PMC13582045
Pivovarcikova K, et al.Virchows Arch. 2026.PMCID: PMC13582045 -
Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey.
- Fanelli GN, Caliò A, Marletta S, Ballotta M, Barella M, Bellezza G, Bianco P, Bonadio AG, Colombo P, D'Amuri A, De Chiara G, Errigo V, Fiorini D, Franzi F, Liscia D, Marcolini L, Onnis D, Pagliuca F, Bonifazi AP, Pierconti F, Pozzi B, Stefanizzi L, Valeri M, Vescovo M, Martignoni G.
- Virchows Arch. 2026 Feb 4;489(3):653-668. doi: 10.1007/s00428-026-04431-3.
- PMCID: PMC13582032
Fanelli GN, et al.Virchows Arch. 2026.PMCID: PMC13582032 -
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors.
- Kwon JW, Tjota MY, Antic T.
- Virchows Arch. 2025 Nov 27;489(3):575-581. doi: 10.1007/s00428-025-04363-4.
- PMCID: PMC13582412
Kwon JW, et al.Virchows Arch. 2025.PMCID: PMC13582412 -
YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma.
- Warmke LM, Ameline B, Fritchie KJ, Dehner CA, Agaimy A, Din NU, Miettinen MM, Dermawan JK, Gross JM, Thangaiah JJ, Chrisinger JSA, Suster DI, Perret R, Le Loarer F, Charville GW, Buehler D, Yeung MCF, Smith BF, Baumhoer D, Davis JL.
- Virchows Arch. Author manuscript. 2024 Dec 6;486(3):457-477. doi: 10.1007/s00428-024-03995-2.
- PMCID: PMC13528201
Warmke LM, et al.Virchows Arch. Author manuscript. 2024.PMCID: PMC13528201 -
Epigenetic alterations in head and neck cancer: a brief update.
- Hellquist H, Castelo-Branco P, Stenman G, Nadal A, Agaimy A, Zidar N, de Lima-Souza RA, Mariano FV, Coca-Pelaz A, Ferlito A.
- Virchows Arch. 2026 Apr 29;489(2):289-295. doi: 10.1007/s00428-026-04528-9.
- PMCID: PMC13477485
Hellquist H, et al.Virchows Arch. 2026.PMCID: PMC13477485 -
PTEN status, tumor immune microenvironment, and survival in colorectal cancer.
- Karjalainen J, Sirkiä O, Sirniö P, Elomaa H, Karjalainen H, Äijälä VK, Kastinen M, Tapiainen VV, Pohjanen VM, Ahtiainen M, Helminen O, Wirta EV, Mattila TT, Lindgren O, Rintala J, Meriläinen S, Saarnio J, Rautio T, Seppälä TT, Böhm J, Mecklin JP, Tuomisto A, Mäkinen MJ, Väyrynen JP.
- Virchows Arch. 2025 Nov 18;489(2):467-476. doi: 10.1007/s00428-025-04327-8.
- PMCID: PMC13477460
Karjalainen J, et al.Virchows Arch. 2025.PMCID: PMC13477460